Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab
…, TC Chan, NWY Leung, WY Lam, FKF Mo… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in
cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing …
cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing …
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular …
Background: Single-agent doxorubicin has been widely used to treat unresectable
hepatocellular carcinoma (HCC), but the response rate is low (<20%) and there is no convincing …
hepatocellular carcinoma (HCC), but the response rate is low (<20%) and there is no convincing …
Overall survival after concurrent cisplatin–radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
…, TSK Mok, S Yau, KT Yuen, FKF Mo… - Journal of the …, 2005 - academic.oup.com
This phase III randomized study compared concurrent cisplatin–radiotherapy (CRT) versus
radiotherapy (RT) alone in patients with locoregionally advanced nasopharyngeal carcinoma…
radiotherapy (RT) alone in patients with locoregionally advanced nasopharyngeal carcinoma…
[PDF][PDF] New utility of an old marker: serial α-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma …
Purpose There are limitations in using radiologic evaluation to assess the treatment outcome
of patients with hepatocellular carcinoma (HCC). The use of serial α-fetoprotein (AFP) in …
of patients with hepatocellular carcinoma (HCC). The use of serial α-fetoprotein (AFP) in …
Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response
Purpose To determine the diagnostic performance of diffusion-weighted (DW) imaging for
the prediction of treatment failure in primary head and neck squamous cell carcinoma (HNSCC…
the prediction of treatment failure in primary head and neck squamous cell carcinoma (HNSCC…
[HTML][HTML] Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
W Yeo, KC Lam, B Zee, PSK Chan, FKF Mo, WM Ho… - Annals of oncology, 2004 - Elsevier
Background Cancer patients who are hepatitis B virus (HBV) carriers and undergoing
chemotherapy (CT) may be complicated by HBV reactivation. Over 80% of hepatocellular …
chemotherapy (CT) may be complicated by HBV reactivation. Over 80% of hepatocellular …
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated …
Background. This study prospectively examines the prognostic role of p53 oncoprotein (p53),
Ki67‐antigen (Ki67), tumor angiogenesis (MVD), epidermal growth factor receptor (EGFR), …
Ki67‐antigen (Ki67), tumor angiogenesis (MVD), epidermal growth factor receptor (EGFR), …
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance
…, NLY Wong, KYY Chan, FKF Mo… - … journal of cancer, 2009 - Wiley Online Library
Genomic gain represents an important mechanism in the activation of proto‐oncogenes. In
many instances, induced oncogenes hold clinical implications both as prognostic markers …
many instances, induced oncogenes hold clinical implications both as prognostic markers …
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic …
…, LZ Wang, R Lim, J Picus, M Boyer, FKF Mo… - Journal of Clinical …, 2012 - ascopubs.org
Purpose Epigenetic aberrations have been reported in hepatocellular carcinoma (HCC). In
this study of patients with unresectable HCC and chronic liver disease, epigenetic therapy …
this study of patients with unresectable HCC and chronic liver disease, epigenetic therapy …
Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response
AD King, FKF Mo, KH Yu, DKW Yeung, H Zhou… - European …, 2010 - Springer
Objective To investigate the role of diffusion-weighted imaging (DWI) in predicting and
monitoring chemoradiotherapy response in head and neck squamous cell carcinoma (HNSCC). …
monitoring chemoradiotherapy response in head and neck squamous cell carcinoma (HNSCC). …